Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outlook Therapeutics (OTLK) Revenue: 2015-2024

Historic Revenue for Outlook Therapeutics (OTLK) over the last 8 years, with Sep 2024 value amounting to -$3.2 million.

  • Outlook Therapeutics' Revenue fell 100.33% to -$19,031 in Q3 2020 from the same period last year, while for Sep 2020 it was -$1.8 million, marking a year-over-year decrease of 121.56%. This contributed to the annual value of -$3.2 million for FY2024, which is 24.72% down from last year.
  • Outlook Therapeutics' Revenue amounted to -$3.2 million in FY2024, which was down 24.72% from -$2.5 million recorded in FY2023.
  • Over the past 5 years, Outlook Therapeutics' Revenue peaked at -$1.8 million during FY2020, and registered a low of -$3.2 million during FY2024.
  • Its 2-year average for Revenue is -$2.8 million, with a median of -$2.8 million in 2023.
  • Data for Outlook Therapeutics' Revenue shows a maximum YoY crashed of 121.56% (in 2020) over the last 5 years.
  • Yearly analysis of 3 years shows Outlook Therapeutics' Revenue stood at -$1.8 million in 2020, then reached -$2.5 million in 2023, then declined by 24.72% to -$3.2 million in 2024.